Abstract
Background
Several patients encompass a scarce weight loss after Roux-en-Y gastric bypass (RYGB). As such event is not related to surgical complications, finding markers able to identify “well responders” and to predict weight loss outcome is clinically relevant. Ghrelin regulates appetite and energy balance. Common single nucleotide polymorphisms (SNPs) in its encoding genes have been associated with body weight regulation. Other peptides involved in satiety modulation, like the CD40/CD40L complex, are less explored.
Methods
One hundred, otherwise healthy, obese subjects (aged 45 ± 11 years, 65 females, BMI 48.0 ± 0.7 kg/m2) were sequentially enrolled in years 2014–2015. SNPs rs2241766 for adiponectin gene, rs490683 for ghrelin receptor, rs696217 and rs27647 for the preproghrelin/ghrelin gene, and rs1126535 for the CD40L gene were determined on DNA extracted from circulating lymphomonocytes. Patients were reevaluated at 6 (n = 100), 26 (n = 91), and 52 weeks (n = 79) after RYGB.
Results
Subjects carrying the rs696217 T allele encompassed a significantly greater reduction in BMI 52 weeks after surgery (GG vs GT 30.5 ± 1.1 vs 38.1 ± 2.1 %; p < 0.001). Carrying the rs1126535 C allele in the CD40L gene was associated with a significantly lower BMI reduction at week 52 (TT vs CT 33.2 ± 1.1 vs 28.1 ± 2.3 %, p = 0.049). rs490683 and rs27647 SNPs of ghrelin and rs2241766 for adiponectin gene did not show any difference between carriers and non-carriers of the mutant allele.
Conclusion
Carrying a G to T substitution in rs696217 (preproghrelin gene) seems to mark a successful weight loss outcome; we also report for the first time that the rs1126535 C allele (CD40L gene) may predict a worse response to bariatric surgery.
Similar content being viewed by others
References
Lopes EC, Heineck I, Athaydes G, Meinhardt NG, Souto KE, Stein AT. Is bariatric surgery effective in reducing comorbidities and drug costs? A systematic review and meta-analysis. Obes Surg. 2015;25(9):1741–9.
Sarwer DB, Steffen KJ. Quality of life, body image and sexual functioning in bariatric surgery patients. Eur Eat Disord Rev. 2015;23(6):504–8.
Brandão I et al. Metabolic profile and psychological variables after bariatric surgery: association with weight outcomes. Eat Weight Disord. 2015;20(4):513–8.
Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab. 2013;17(2):185–96.
Moschen AR, Wieser V, Tilg H. Adiponectin: key player in the adipose tissue-liver crosstalk. Curr Med Chem. 2012;19(32):5467–73.
Kubota N et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 2007;6(1):55–68.
Müller TD, Tschöp MH. Ghrelin—a key pleiotropic hormone-regulating systemic energy metabolism. Endocr Dev. 2013;25:91–100.
Shin MJ et al. The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss. Int J Obes. 2006;30(12):1702–8.
Goyenechea E et al. The - 11391 G/A polymorphism of the adiponectin gene promoter is associated with metabolic syndrome traits and the outcome of an energy-restricted diet in obese subjects. Horm Metab Res. 2009;41(1):55–61.
Gueorguiev M et al. Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity. Obesity (Silver Spring). 2009;17(4):745–54.
Monteleone P, Tortorella A, Castaldo E, Di Filippo C, Maj M. The Leu72Met polymorphism of the ghrelin gene is significantly associated with binge eating disorder. Psychiatr Genet. 2007;17(1):13–6.
Mager U et al. Finnish diabetes prevention study group. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of type 2 diabetes in subjects with impaired glucose tolerance in the Finnish diabetes prevention study. Diabet Med. 2006;23(6):685–9.
Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol. 2009;54(8):669–77.
Li J et al. CHANCE investigators. Soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack. Stroke. 2015;46(7):1990–2.
Guo CA et al. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance. Am J Physiol Endocrinol Metab. 2013;304(9):E951–63.
Baena-Fustegueras JA et al. Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery. JAMA Surg. 2013;148(2):151–6.
Schernthaner GH, Kopp HP, Krzyzanowska K, Kriwanek S, Koppensteiner R, Schernthaner G. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. Eur J Clin Investig. 2006;36(6):395–401.
Chen JM et al. The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus. BMC Genet. 2015;16:121.
Hu CY, Zhang XA, Meyer CG, Thye T, Liu W, Cao WC. Polymorphism of X-linked CD40 ligand gene associated with pulmonary tuberculosis in the Han Chinese population. Genes Immun. 2015;16(6):399–404.
Ukkola O. Genetic variants of ghrelin in metabolic disorders. Peptides. 2011;32(11):2319–22.
Mager U et al. Finnish diabetes prevention study group. Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance. PLoS One. 2008;3(8):e2941.
Siitonen N et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish diabetes prevention study. BMC Med Genet. 2011;12:5.
Ghalandari H, Hosseini-Esfahani F, Mirmiran P. The association of polymorphisms in leptin/leptin receptor genes and ghrelin/ghrelin receptor genes with overweight/obesity and the related metabolic disturbances: a review. Int J Endocrinol Metab. 2015;13(3):e19073.
Hosoda H, Kojima M, Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci. 2006;100(5):398–410.
Ukkola O et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res. 2002;10(8):782–91.
Tang N-P et al. Preproghrelin Leu72Met polymorphism in Chinese subjects with coronary artery disease and controls. Clin Chim Acta. 2008;387:42–7.
Saliba LF et al. Obesity-related gene ADRB2, ADRB3 and GHRL polymorphisms and the response to a weight loss diet intervention in adult women. Genet Mol Biol. 2014;37(1):15–22.
Vivenza D et al. Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. Eur J Endocrinol. 2004;151(1):127–33.
Zavarella S et al. A new variation in the promoter region, the −604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance. Int J Obes. 2008;32:663–8.
Korbonits M et al. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab. 2002;87(8):4005–8.
Pineda B, Tarín JJ, Hermenegildo C, Laporta P, Cano A, García-Pérez MÁ. Gene-gene interaction between CD40 and CD40L reduces bone mineral density and increases osteoporosis risk in women. Osteoporos Int. 2011;22(5):1451–8.
Unek IT et al. The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people. Clin Med Res. 2010;8(2):89–95.
Guldiken S et al. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res. 2007;119(1):79–84.
Zhang M, Yuan F, Chen H, Qiu X, Fang W. Effect of exogenous ghrelin on cell differentiation antigen 40 expression in endothelial cells. Acta Biochim Biophys Sin Shanghai. 2007;39(12):974–81.
Matzko ME, Argyropoulos G, Wood GC, Chu X, McCarter RJ. Still CD et al. Association of ghrelin receptor promoter polymorphisms with weight loss following roux-en-Y gastric bypass surgery. Obes Surg. 2012;22(5):783–90.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Grant Information and Support
This study has been supported by an institutional grant of the University of Pisa.
Conflict of Interest
The authors declare that hey have no conflict of interest.
Ethical Statement
The protocol was approved by the Ethics Committee of the University of Pisa (n3463/2011).
Informed consent
All participants in this study read and signed an informed consent.
Additional information
E. Vitolo and E. Santini share the first authorship
Electronic supplementary material
Suppl Table 1
(DOCX 28 kb)
Suppl Table 2
(DOCX 31 kb)
Rights and permissions
About this article
Cite this article
Vitolo, E., Santini, E., Seghieri, M. et al. Heterozygosity for the rs696217 SNP in the Preproghrelin Gene Predicts Weight Loss After Bariatric Surgery in Severely Obese Individuals. OBES SURG 27, 961–967 (2017). https://doi.org/10.1007/s11695-016-2387-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-016-2387-6